Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

Kisunla

Australian Public Assessment Report

AusPAR

AusPAR: Kisunla [PDF, 1.54 MB]

AusPAR: Kisunla [DOCX, 6.77 MB]

Attachment: Product information for Kisunla [PDF, 510.54 KB]

Attachment: Product information for Kisunla [DOCX, 338.81 KB]

Device/Product Name

Kisunla

Active ingredients

Donanemab

AusPAR Date

28 May 2025

Published

29 May 2025

Submission Number

PM-2023-03683-1-1

Submission Type

New chemical entity

Decision

Approved 19 May 2025

Product types

Prescription medicines